Drug Delivery

Drug Delivery is a fully open access journal published by Taylor & Francis since 1993, covering the design, targeting and application of drug delivery systems, with a 2025 Journal Impact Factor of 8.0 and a first-quartile rank of 24 of 356 in pharmacology and pharmacy《药物递送》（Drug Delivery）是（Taylor & Francis）自 1993 年起出版的完全开放获取期刊，覆盖药物递送系统的设计、靶向与应用，2025 年影响因子为 8.0，在药理学与药学类 356 种期刊中列第 24 位，居第一四分位。

Scope

• The journal publishes comprehensive peer-reviewed research articles on the development and application principles of drug delivery and targeting at molecular, cellular and higher levels该刊刊载经同行评审的完整研究论文，关注分子、细胞及更高层次的药物递送与靶向原理及应用。
• It covers drug delivery system design and engineering for the main routes of administration, including oral, pulmonary, nasal, parenteral and transdermal delivery其覆盖口服、肺、鼻、注射与经皮等主要给药途径的药物递送系统设计与工程。
• Formulation topics include controlled release systems and 3D printed dosage forms, together with the development of new materials with emphasis on biologics and biopharmaceutical delivery and biomimetic design strategies制剂方向包括控释系统与三维打印剂型，以及以生物制品与生物药物递送为重心的新材料开发与仿生设计策略。
• Nanomedicine and targeted delivery are central, covering lipid and polymer based nanoparticles, macromolecular conjugates, antibodies, nucleic acid delivery and gene editing systems as well as theranostics纳米医学与靶向递送是核心方向，涉及脂质与高分子纳米粒、大分子偶联物、抗体、核酸递送与基因编辑系统，以及诊疗一体化。
• Fundamental studies on how delivery systems and nanomedicines interact with biological systems in vitro and in vivo are welcomed, alongside systems approaches, toxicology and the safety of delivery systems该刊欢迎递送系统与纳米药物在体外和体内与生物系统相互作用的基础研究，以及系统方法学、毒理学与递送系统安全性研究。
• Further topics include artificial intelligence, machine learning and computational analysis in formulation engineering, controlled delivery in veterinary medicine, alternatives to animal testing, and industrial and regulatory issues, while bibliometric analyses are not accepted其他方向包括制剂工程中的人工智能、机器学习与计算分析，兽医学中的控释递送，动物实验替代方法，以及产业与监管问题；该刊不接受文献计量分析类稿件。

History

• Drug Delivery was founded in 1993, with its earliest indexed articles dating from that year, and it was published for many years by Informa Healthcare before passing to Taylor & Francis该刊创刊于 1993 年，可检索到的最早论文即出自该年，长期由（Informa Healthcare）出版，后转由（Taylor & Francis）出版。
• At present the journal is published from Abingdon in the United Kingdom by Taylor & Francis and appears in nine issues per year现由（Taylor & Francis）在英国阿宾登出版，每年出版 9 期。
• It has become a fully open access journal that only publishes open access articles, so all content is free to read online immediately upon publication该刊已转为完全开放获取期刊，只发表开放获取文章，所有内容在出版后即可免费在线阅读。
• Its Journal Impact Factor stood at 6.419 in 2021 and 6.819 in 2022, then 8.1 in 2024 and 8.0 in 2025其影响因子 2021 年为 6.419、2022 年为 6.819，2024 年版为 8.1、2025 年版为 8.0。
• The journal is indexed in PubMed and MEDLINE, the Science Citation Index, Scopus, DOAJ, EMBASE and Chemical Abstracts, and its CODEN is DDELEB该刊被（PubMed）与（MEDLINE）、（Science Citation Index）、（Scopus）、（DOAJ）、（EMBASE）与（Chemical Abstracts）收录，CODEN 为（DDELEB）。

Editors

• The Editor-in-Chief is Moein Moghimi, Professor of Nanomedicine and Pharmaceutics at Newcastle University in the United Kingdom and an adjunct professor at the University of Colorado Anschutz Medical Campus in the United States现任主编为 Moein Moghimi，他是英国纽卡斯尔大学的纳米医学与药剂学教授，并兼任美国科罗拉多大学安舒茨医学院的客座教授。
• Associate Editors are Ying Chau of the Hong Kong University of Science and Technology and Snow Stolnik of the University of Nottingham in the United Kingdom副编辑为香港科技大学的 Ying Chau 与英国诺丁汉大学的 Snow Stolnik。
• Advisory Editors are Patrick Couvreur, emeritus professor of pharmacy at Paris-Saclay University in France, and Robert Langer of the Massachusetts Institute of Technology顾问编辑为法国巴黎萨克雷大学药学荣休教授 Patrick Couvreur 与美国麻省理工学院的 Robert Langer。
• The editorial board of some thirty members is drawn from Canada, Belgium, France, Japan, Korea, the United States, Germany, China, Singapore, Israel, Italy, Spain and Turkey, and includes Christine Allen, Kevin Braeckmans, Mitsuru Hashida, Sangyong Jon, Rakesh K. Jain, Claus-Michael Lehr, Ernst Wagner, Wei Wu and Yi Yan Yang编委会约三十人，来自加拿大、比利时、法国、日本、韩国、美国、德国、中国、新加坡、以色列、意大利、西班牙与土耳其，成员包括 Christine Allen、Kevin Braeckmans、Mitsuru Hashida、Sangyong Jon、Rakesh K. Jain、Claus-Michael Lehr、Ernst Wagner、Wei Wu 与 Yi Yan Yang。
• An Early Career Board of eight members based in Spain, Italy, China and the United States supports the journal, peer review is single-anonymous, and perspectives and editorials are published by invitation only该刊设有八人的青年编委（Early Career Board），成员分布于西班牙、意大利、中国与美国；评审采用单匿名方式，观点与社论类文章仅接受邀约稿件。